Glassman Wealth Services’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-2,382
| Closed | -$68.5K | – | 194 |
|
2024
Q1 | $68.5K | Hold |
2,382
| – | – | 0.01% | 102 |
|
2023
Q4 | $78.2K | Hold |
2,382
| – | – | 0.01% | 344 |
|
2023
Q3 | $66.4K | Buy |
+2,382
| New | +$66.4K | 0.01% | 354 |
|
2023
Q1 | – | Sell |
-3,695
| Closed | -$104K | – | 1899 |
|
2022
Q4 | $104K | Buy |
3,695
+1,150
| +45% | +$32.5K | 0.02% | 261 |
|
2022
Q3 | $84K | Hold |
2,545
| – | – | 0.02% | 274 |
|
2022
Q2 | $80K | Hold |
2,545
| – | – | 0.02% | 296 |
|
2022
Q1 | $117K | Buy |
+2,545
| New | +$117K | 0.02% | 232 |
|
2021
Q4 | – | Sell |
-1,847
| Closed | -$138K | – | 1626 |
|
2021
Q3 | $138K | Hold |
1,847
| – | – | 0.03% | 191 |
|
2021
Q2 | $171K | Buy |
1,847
+411
| +29% | +$38.1K | 0.04% | 160 |
|
2021
Q1 | $127K | Buy |
1,436
+805
| +128% | +$71.2K | 0.03% | 194 |
|
2020
Q4 | $59K | Hold |
631
| – | – | 0.01% | 311 |
|
2020
Q3 | $40K | Hold |
631
| – | – | 0.01% | 334 |
|
2020
Q2 | $33K | Hold |
631
| – | – | 0.01% | 310 |
|
2020
Q1 | $20K | Buy |
631
+20
| +3% | +$634 | 0.01% | 339 |
|
2019
Q4 | $21K | Sell |
611
-1
| -0.2% | -$34 | 0.01% | 367 |
|
2019
Q3 | $18K | Hold |
612
| – | – | 0.01% | 364 |
|
2019
Q2 | $21K | Hold |
612
| – | – | 0.01% | 358 |
|
2019
Q1 | $20K | Buy |
612
+12
| +2% | +$392 | 0.01% | 352 |
|
2018
Q4 | $14K | Hold |
600
| – | – | 0.01% | 332 |
|
2018
Q3 | $20K | Buy |
+600
| New | +$20K | 0.01% | 324 |
|